David Pyott

Track

Insider profile

Currently holds a position at Biomarin Pharmaceutical Inc

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 56% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Biomarin Pharmaceutical Inc Jan. 4, 2016 -
David Pyott's trades of Alnylam Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
299.51
Quantity 3,830
Value US$1,147,123
Transaction date
Proposed sale
Price
299.00
Quantity 7,440
Value US$2,224,560
Transaction date
Proposed sale
Price
220.69
Quantity 32,450
Value US$7,161,360
Transaction date
Purchase
Price
32.65
Quantity 19,000
Value US$620,350
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-01
PlS Planned sale
7,156 -10.0%
35.03
US$3,787,316 		7,156 -10.0% 35.03 US$3,787,316
2026-06-03 2026-06-01
PlS Planned sale
48,360 -10.9%
420.25
US$141,331 		48,360 -10.9% 420.25 US$141,331
2026-06-03 2026-06-01
PlS Planned sale
19,414 +39.9%
401.04
US$2,014,753 		19,414 +39.9% 401.04 US$2,014,753
2026-06-03 2026-06-01
PlS Planned sale
1,175 -26.2%
298.91
US$351,219 		1,175 -26.2% 298.91 US$351,219
2026-06-03 2026-06-01
PlS Planned sale
921 -17.0%
297.71
US$274,191 		921 -17.0% 297.71 US$274,191
2026-06-01 2026-06-01
PrS Proposed sale
3,830
299.51
US$1,147,123 		3,830 299.51 US$1,147,123
2025-03-25 2025-03-24
PlS Planned sale
7,440 -98.2%
299.00
US$2,224,560 		7,440 -98.2% 299.00 US$2,224,560
2025-03-24 2025-03-24
PrS Proposed sale
7,440
299.00
US$2,224,560 		7,440 299.00 US$2,224,560
2024-06-26 2024-06-24
PlS Planned sale
7,470 -98.2%
222.00
US$1,658,340 		7,470 -98.2% 222.00 US$1,658,340
2024-06-26 2024-06-24
PlS Planned sale
7,420 -49.4%
221.00
US$1,639,820 		7,420 -49.4% 221.00 US$1,639,820
2024-06-26 2024-06-24
PlS Planned sale
17,560 -53.9%
220.00
US$3,863,200 		17,560 -53.9% 220.00 US$3,863,200
2024-06-24 2024-06-24
PrS Proposed sale
32,450
220.69
US$7,161,360 		32,450 220.69 US$7,161,360
2022-01-26 2022-01-26
B Purchase
19,000
32.65
US$620,350 		19,000 32.65 US$620,350
2020-09-01 2020-08-31
B Purchase
900 +3.0%
78.84
US$70,955 		900 +3.0% 78.84 US$70,955
2020-09-01 2020-08-31
B Purchase
11,900 +66.3%
78.22
US$930,760 		11,900 +66.3% 78.22 US$930,760
2020-02-05 2020-02-03
S Sale
5,027 -22.5%
132.72
US$667,183 		5,027 -22.5% 132.72 US$667,183